Advertisement

Picture EBD Group World of Partnering Opportunities 650x100px
Document › Details

Abzena plc. (8/16/18). "Press Release: Recommended Cash Offer for Abzena plc [NOT FOR RELEASE WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF SUCH JURISDICTION]".

Organisations Organisation Abzena plc (AIM: ABZA)
  Today Abzena Ltd. (since 2018)
  Group Abzena (Group)
  Organisation 2 Welsh, Carson, Anderson and Stowe XII, L.P. (WCAS XII)
  Group Welsh, Carson, Anderson & Stowe (WCAS)
Products Product drug development services
  Product 2 private equity
Index term Index term Abzena–Welsh Carson Anderson & Stowe: investment, 201808– recommended cash offer 16p/share valueing Abzena at £34.4m by WCAS XII-Astra LP
Persons Person Goldman, Jonathan (Abzena 202201 CEO formerly Aptuit CEO)
  Person 2 Burt, John (Abzena 201405– CEO before Antitope + PolyTherics + Thiakis)
     


   
Record changed: 2023-06-05

Advertisement

Picture Swiss Biotech Association Swiss Biotech Days 2024 SBD24 Basel 650x200px

More documents for Abzena (Group)


To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Advertisement

Picture Berlin Partner Top News Bayer Aignostics Collaboration 650x300px




» top